Results for tag: "Thrombocythemia Drug"

Thrombocythemia is a rare blood disorder characterized by an abnormally high number of platelets in the blood. Treatment for thrombocythemia typically involves medications that reduce the number of platelets in the blood, such as hydroxyurea, anagrelide, and interferon-alpha. These medications are part of the hematological drug market, which includes drugs used to treat a variety of blood disorders, including anemia, leukemia, and lymphoma. The hematological drug market is highly competitive, with a number of large pharmaceutical companies offering a range of treatments. Some of the major players in the market include Novartis, Pfizer, Amgen, and Bristol-Myers Squibb. Other companies, such as Celgene, Merck, and Johnson & Johnson, also offer treatments for thrombocythemia. Show Less Read more